Amalgamated Bank Iveric Bio, Inc. Transaction History

Amalgamated Bank

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$26.24 - $39.63 $46,182 - $69,748	1,760 Added 9.16%	20,965 $824,000
Q1 2023 May 02, 2023	SELL	$18.67 - $24.56 $60,322 - $79,353	-3,231 Reduced 14.4%	19,205 $467,000
Q4 2022 Feb 10, 2023	BUY	$17.24 - $23.95 $56,236 - $78,124	3,262 Added 17.01%	22,436 $480,000
Q3 2022 Nov 09, 2022	BUY	$9.4 - $18.59 $7,632 - $15,095	812 Added 4.42%	19,174 $344,000
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $31,919 - $66,150	3,500 Added 23.55%	18,362 $177,000
Q1 2022 Jun 30, 2022	SELL	$12.15 - $16.83 $12,915 - $17,890	-1,063 Reduced 6.68%	14,862 $250,000
Q4 2021 Feb 15, 2022	BUY	$13.83 - $18.78 $18,352 - $24,921	1,327 Added 9.09%	15,925 $266,000
Q3 2021 Oct 29, 2021	BUY	$7.07 - $17.5 $7,048 - $17,447	997 Added 7.33%	14,598 $237,000
Q2 2021 Aug 16, 2021	BUY	$5.69 - $7.17 $77,389 - $97,519	13,601 New	13,601 $86,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.